PDMP Communications Development

The Maryland Department of Health (MDH or the Department), Office of Population Health Improvement (OPHI), Prescription Drug Monitoring Program (PDMP), is issuing this Request for Proposals (RFP) to provide services to meet the deliverables established in the Overdose Data to Action (OD2A) grant. [...] Specifically, the selected Offeror will develop creative assets to be disseminated through an upcoming multimedia communications campaign. This will entail creating and updating print and digital educational materials; training videos; as well as website and social media content and assets. The period of performance shall be from the date of the award, through February 28, 2027.

The Department intends to make a single award as a result of this RFP.

The Contractor shall conduct a comprehensive review of the PDMP's current educational initiatives, including all print and digital educational materials, training videos, as well as website and social media content and assets.

• Propose and submit a detailed workplan, subject to PDMP review and approval, following a comprehensive review of its current educational initiatives.
• Develop and submit a comprehensive timeline, subject to PDMP review and approval, for the creation of new PDMP training videos; the update of current materials and assets; and development of new educational materials and assets (e.g., fact sheets, Academic Detailing materials, and other clinically relevant resources).
• Meet with the PDMP at a mutually agreed-upon cadence to regularly review workplan progress throughout the duration of services.

The Contractor shall implement a target audience-centered creative strategy to develop clinically relevant, high impact new PDMP training videos and educational materials and assets to be widely disseminated to Maryland healthcare providers and pharmacists.

• Update existing PDMP educational materials and assets including, but not limited to, fact sheets, recommended resource lists, and clinical tools/guidance documents (a minimum of 10 documents, subject to PDMP review and approval).
• Create new PDMP training videos, as well as print- and digital-ready assets, based on new legislation and updates in evidence-based clinical practice guidelines. Assets could include, but are not limited to, fact sheets, brochures, interactive infographics, PowerPoint slides, website content or assets, promotional materials, and social media content or assets (a minimum of 3, subject to PDMP review and approval).

Final draft deliverables are due by January 15, 2027 for review. The period from January 15 - February 28, 2027 shall be used for soliciting and incorporating stakeholder feedback, iterative revisions, and other updates prior to final review of deliverables.

**Proposals must be submitted via eMaryland Marketplace Advantage (eMMA - https://emma.maryland.gov/)** by the listed due date and time. Technical and Financial proposals submitted in eMMA are due by **4:00 p.m. Eastern Time on November 12, 2026**, in order to be considered. Proposals received outside eMMA will not be considered.

Offerors shall submit Proposals to eMMA in two separate volumes:

• Volume I – Technical Proposal
• Volume II – Financial Proposal

No pricing information is to be included in the Technical Proposal. The Technical Proposal should not be more than ten (10) pages (standard letter size, 12 pt. font).

The contract to result from this solicitation will be awarded to the offeror submitting the Most Advantageous Offer. The final award recommendation will be based on a weighted analysis of the technical and financial proposals, with technical factors given a greater weight.

The term of this contract is projected to be December 1, 2026 – February 28, 2027. The resulting contract shall be firm fixed price.

This is a **Small Business Reserve Procurement** for which the award will be limited to certified small businesses.